Metformin : : pharmacology and drug interactions / / Juber Akhtar [and three others], editor.

Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including th...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:London : : IntechOpen,, 2021.
Year of Publication:2021
Language:English
Physical Description:1 online resource (154 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603420804498
ctrlnum (CKB)5400000000044877
(NjHacI)995400000000044877
(EXLCZ)995400000000044877
collection bib_alma
record_format marc
spelling Metformin : pharmacology and drug interactions / Juber Akhtar [and three others], editor.
Metformin
London : IntechOpen, 2021.
1 online resource (154 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including the oral agent metformin. This medication is recommended as first-line treatment for T2D, except for those patients with severe kidney or liver problems. This book discusses the molecular mechanism, pharmacokinetics, and uses of metformin, as well as presents information on adverse drug reactions, drug interactions, and the potential use of metformin in tuberculosis.
Metformin.
1-83969-607-9
Akhtar, Juber, editor.
language English
format eBook
author2 Akhtar, Juber,
author_facet Akhtar, Juber,
author2_variant j a ja
author2_role TeilnehmendeR
title Metformin : pharmacology and drug interactions /
spellingShingle Metformin : pharmacology and drug interactions /
title_sub pharmacology and drug interactions /
title_full Metformin : pharmacology and drug interactions / Juber Akhtar [and three others], editor.
title_fullStr Metformin : pharmacology and drug interactions / Juber Akhtar [and three others], editor.
title_full_unstemmed Metformin : pharmacology and drug interactions / Juber Akhtar [and three others], editor.
title_auth Metformin : pharmacology and drug interactions /
title_alt Metformin
title_new Metformin :
title_sort metformin : pharmacology and drug interactions /
publisher IntechOpen,
publishDate 2021
physical 1 online resource (154 pages)
isbn 1-83969-607-9
callnumber-first Q - Science
callnumber-subject QP - Physiology
callnumber-label QP801
callnumber-sort QP 3801 M39 M484 42021
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.462061
dewey-sort 3616.462061
dewey-raw 616.462061
dewey-search 616.462061
work_keys_str_mv AT akhtarjuber metforminpharmacologyanddruginteractions
AT akhtarjuber metformin
status_str n
ids_txt_mv (CKB)5400000000044877
(NjHacI)995400000000044877
(EXLCZ)995400000000044877
carrierType_str_mv cr
is_hierarchy_title Metformin : pharmacology and drug interactions /
author2_original_writing_str_mv noLinkedField
_version_ 1796653218153889792
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01552nam a2200277 i 4500</leader><controlfield tag="001">993603420804498</controlfield><controlfield tag="005">20230701032349.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230701s2021 enk o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044877</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000044877</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044877</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP801.M39</subfield><subfield code="b">.M484 2021</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.462061</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Metformin :</subfield><subfield code="b">pharmacology and drug interactions /</subfield><subfield code="c">Juber Akhtar [and three others], editor.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Metformin </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2021.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (154 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Type 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including the oral agent metformin. This medication is recommended as first-line treatment for T2D, except for those patients with severe kidney or liver problems. This book discusses the molecular mechanism, pharmacokinetics, and uses of metformin, as well as presents information on adverse drug reactions, drug interactions, and the potential use of metformin in tuberculosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Metformin.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83969-607-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Akhtar, Juber,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:18:52 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5351665950004498&amp;Force_direct=true</subfield><subfield code="Z">5351665950004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351665950004498</subfield></datafield></record></collection>